the
cancer
collab
orative
lecollab
oratoire
cancer
#travelwithcolab
this year promises to be another filled with interesting conversations, dynamic dialogues and learning, lots of learning – across the...
ASCO 2020 clinical advances of the year
ASCO has published their annual report on progress against cancer – the report highlights the most important clinical research advances...
the future of healthcare is personalized
rapid advances of the molecular pathways that underlie cancer combined with an expansion of the tools at our disposal to diagnose and...
war on cancer2019—celebrating success, accelerating progress
cancer is a global problem, with countries worldwide struggling to keep pace with the speed of innovation, budgetary constraints and...
if not now, when?
do we want an innovative canada or are we ok with a balanced-book kind of canada? if that isn’t the million dollar question these days....
car-t. one year later
on september 5.2018 health canada gave a notice of compliance [NOC] for tisagenlecleucel [kymriah]. it was the first chimeric antigen...
biosimilars are not just a cost saving opportunity but the opportunity to create a more sustainable
biosimilars provide an opportunity to manage the incoming innovation in oncology and to create a more sustainable healthcare system. but...
managing expectations
car t-cell therapy is the next big cancer treatment hitting the canadian cancer treatment landscape— with one recently approved car...
how car-t is an opportunity for canada
the arrival of car t-cell therapy is disrupting the canadian healthcare system, but it has also offered an opportunity for canada to...
biosimilars. the european experience
the cancer collaborative hosted a webinar on June 19 2019 with jatinder harchowal from the NHS whereby he provided insight into the NHS’...
tweets, chats, and posts: using social media to transcend boundaries & create opportunities for pts
patients are eager for participatory discussions and those who participate in those discussions demonstrate high rates of knowledge...
cancer injustice is not a science problem, a technology problem, or a genetics problem. it’s a
from the ASCO plenary june 1, 2019 there is a large volume of evidence that racial disparities exist in cancer outcomes and access to...
it’s that time of year!
pre-ASCO highlights 2019 it’s that time of year again. the world of oncology is gathering in chicago this weekend for the american...
biosimilars. past talk to action
biosimilars aren’t coming, they’re here. in 2010 health canada published the HC Guidance document: information and submission...